Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Safety of rapid infusion of iron polymaltose: comparative study in 300 patients

Chan PTY, Corallo CE, Dooley MJ, Poole SG, Gibson PR

(2016), J Pharm Pract Res, 46(4),

A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Non Alcoholic Fatty Liver Disease (MEDINA): study protocol

Papamiltiadous ES, Roberts SK, Nicoll AJ, Ryan MC, Itsiopoulos C, Salim A, Tierney AC

(2016), BMC Gastroenterol, 16,

Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis

Kao JH, Jensen DM, Manns MP, Jacobson I, Kumada H, Toyota J, Heo J, Yoffe B, Sievert W, Bessone F, Peng CY, Roberts SK, Lee YJ, Bhore R, Mendez P, Hughes E, Noviello S

(2016), Liver Int, 36(7),

Adherence to the gluten-free diet can achieve the therapeutic goals in almost all patients with coeliac disease: a 5-year longitudinal study from diagnosis

Newnham ED, Shepherd SJ, Strauss BJ, Hosking P, Gibson PR

(2016), J Gastroenterol Hepatol, 31(2),

Ultrathin unsedated transnasal gastroscopy in monitoring eosinophilic esophagitis

Philpott H, Nandurkar S, Royce SG, Gibson PR

(2016), J Gastroenterol Hepatol, 31(3),

The Crohn's disease-ulcerative colitis clinical appraisal

D'Haens G, Bressler B, Danese S, Gibson P, Hanauer SB, Sandborn W

(2016), Clin Gastroenterol Hepatol, 14(4),

Relationship between vitamin D status and response to hepatitis C virus therapy

Kitson MT, Sarrazin C, Toniutto P, Roberts SK

(2015), Hepatology, 62(5), 1642-3

Reply to: "Evidence supporting a beneficial role of vitamin D in chronic hepatitis C"

Kitson MT, Sarrazin C, Toniutto P, Roberts SK

(2015), J Hepatol, 63(2), 531-2

Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study

Moss A, Williams SJ, Hourigan LF, Brown G, Tam W, Singh R, Zanati S, Burgess NG, Sonson R, Byth K, Bourke MJ

(2015), Gut, 64(1), 57-65

Right-sided adenoma detection with retroflexion versus forward-view colonoscopy

Chandran S, Parker F, Vaughan R, Mitchell B, Fanning S, Brown G, Yu J, Efthymiou M

(2015), Gastrointest Endosc, 81(3), 608-13

Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response

Ghaly S, Costello S, Beswick L, Pudipeddi A, Agarwal A, Sechi A, Antoniades S, Headon B, Connor S, Lawrance IC, Sparrow M, Walsh AJ, Andrews JM; AIBDA

(2015), Intern Med J, 45(2), 170-7

Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients

Costello SP, Ghaly S, Beswick L, Pudipeddi A, Agarwal A, Sechi A, O'Connor S, Connor SJ, Sparrow MP, Bampton P, Walsh AJ, Andrews JM; Australian Inflammatory Bowel Disease Association (AIBDA)

(2015), Intern Med J, 45(6), 659-66

Lipidomic profiling in inflammatory bowel disease: comparison between ulcerative colitis and Crohn's disease

Fan F, Mundra PA, Fang L, Galvin A, Moore XL, Weir JM, Wong G, White DA, Chin-Dusting J, Sparrow MP, Meikle PJ, Dart AM

(2015), Inflamm Bowel Dis, 21(7), 1511-8

Effects of concomitant immunomodulator therapy on efficacy and safety of anti-tumor necrosis factor therapy for Crohn's disease: a meta-analysis of placebo-controlled trials

Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L, Devlin S, Melmed GY, Tanyingoh D, Raffals L, Irving P, Kozuch P, Sparrow M, Velayos F, Bressler B, Cheifetz A, Colombel JF, Siegel CA

(2015), Clin Gastroenterol Hepatol, 13(13), 2233-40.e1-2

Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study

Gory I, Fink M, Bell S, Gow P, Nicoll A, Knight V, Dev A, Rode A, Bailey M, Cheung W, Kemp W, Roberts SK; Melbourne Liver Group

(2015), Scand J Gastroenterol, 50(5), 567-76

Sofosbuvir plus velpatasvir combination therapy for treatment-experienced patients with genotype 1 or 3 hepatitis C virus infection: a randomized trial

Pianko S, Flamm SL, Shiffman ML, Kumar S, Strasser SI, Dore GJ, McNally J, Brainard DM, Han L, Doehle B, Mogalian E, McHutchison JG, Rabinovitz M, Towner WJ, Gane EJ, Stedman CA, Reddy KR, Roberts SK

(2015), Ann Intern Med, 163(11), 809-17

The cascade of care for an Australian community-based hepatitis C treatment service

Wade AJ, Macdonald DM, Doyle JS, Gordon A, Roberts SK, Thompson AJ, Hellard ME

(2015), PLoS One, 10(11), e0142770

Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection

Foster GR, Afdhal N, Roberts SK, Bräu N, Gane EJ, Pianko S, Lawitz E, Thompson A, Shiffman ML, Cooper C, Towner WJ, Conway B, Ruane P, Bourlière M, Asselah T, Berg T, Zeuzem S, Rosenberg W, Agarwal K, Stedman CA, Mo H, Dvory-Sobol H, Han L, Wang J, McNally J, Osinusi A, Brainard DM, McHutchison JG, Mazzotta F, Tran TT, Gordon SC, Patel K, Reau N, Mangia A, Sulkowski M; ASTRAL-2 Investigators; ASTRAL-3 Investigators

(2015), N Engl J Med, 373(27), 2608-17

ITPA genotypes predict anemia but do not affect virological response with interferon-free faldaprevir, deleobuvir, and ribavirin for HCV infection

Asselah T, Zeuzem S, Soriano V, Bronowicki JP, Lohse AW, Müllhaupt B, Schuchmann M, Bourlière M, Buti M, Roberts SK, Gane EJ, Stern JO, Voss F, Baum P, Gallivan JP, BÖcher WO, Mensa FJ

(2015), PLoS One, 10(12), e0144004

HCV-infected patients need access now to new direct-acting antiviral agents to avert liver-related deaths

Sievert W, Razavi H, Thompson A, Zekry A, Dore GJ, Roberts SK

(2015), Med J Aust, 202(9), 479

13 14 15 16 17